YPrime's ESG

Transformation

SUSTAINABILITY CASE STUDY

Tight EcoVadis & CDP submission deadlines

Low initial ESG scores

Limited in-house expertise and capacity

High customer expectations for rapid improvement

YPrime, a global leader in clinical trial technology, faced urgent pressure to improve their ESG performance.

YPrime’s ESG journey is proof that rapid, measurable change is possible. In just 12 weeks, they jumped to the 73rd percentile in EcoVadis and improved their CDP score to a B—with Vantix Operation’s hands-on expertise.

Key Actions & Solutions

Gap Analysis

Created ESG transformation plan based on our in-depth gap analysis across all 4 EcoVadis pillars.

ESG Program Revamp

Launched comprehensive sustainability program (SBTi, CDP, labor & human rights).

Policy & Compliance

Wrote GRI-aligned policies and documentation for implementation.

Strategic Allies

Joined high-impact sustainability coalitions.

Hands-on Support

Answered EcoVadis & CDP questionnaires to showcase ESG journey and maximize scoring.

Vantix Turned Complex Pharma ESG Mandates into Clarity, Compliance & Results

77% score improvement (27-point increase)

From 13th to 73rd percentile in EcoVadis, outperforming 157K companies assessed worldwide

CDP score improved from D to B

Copy of Shared - Vantix Capabilities & Products 7-Nov-2025.png

The Vantix Solution

In depth gap analysis across all four EcoVadis

Launch of a robust sustainability roadmap

GRI-aligned policies & documentation

Strategic coalition partners for maximum impact

Hands-on support answering EcoVadis & CDP questionnaires

YPrime's ESG Transformation SUSTAINABILITY CASE STUDY